Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-13

Clinical Trial Update: Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer [NA]

View source ↗

Summary

A terminated clinical trial comparing dosimetry after recombinant human TSH (rhTSH) versus withdrawal of thyroid hormone in metastatic or locally advanced thyro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thyrogen (thyrotropin alfa)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Thyroid Cancer, Metastases | NA | Status: TERMINATED